ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Gio Gori And The “Tolerable” Smoking Flap; Controversy When He Needs It Least

August 18, 1978

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994

In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems

July 26, 1985

Committee Approves Concepts For Studies In Special Populations

December 11, 1987